Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 3/12/2026 | $66.00 | Neutral → Overweight | Piper Sandler | |
| 3/12/2026 | $69.00 | Underweight → Overweight | Wells Fargo | |
| 3/4/2026 | $460.00 | Buy | BofA Securities | |
| 2/23/2026 | $305.00 → $304.00 | Overweight | Wells Fargo | |
| 2/19/2026 | Buy → Hold | D. Boral Capital | ||
| 2/13/2026 | $220.00 | Neutral | DA Davidson | |
| 2/12/2026 | $550.00 | Buy | Tigress Financial | |
| 2/6/2026 | $300.00 → $280.00 | Buy | Monness Crespi & Hardt |
For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr
For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there
Piper Sandler upgraded Occidental Petro from Neutral to Overweight and set a new price target of $66.00
Wells Fargo upgraded Occidental Petro from Underweight to Overweight and set a new price target of $69.00
BofA Securities resumed coverage of Tesla with a rating of Buy and set a new price target of $460.00
4 - ADVANCED MICRO DEVICES INC (0000002488) (Issuer)
4 - SIGA TECHNOLOGIES INC (0001010086) (Issuer)
4 - SIGA TECHNOLOGIES INC (0001010086) (Issuer)
4 - OCCIDENTAL PETROLEUM CORP /DE/ (0000797468) (Issuer)
4 - Tesla, Inc. (0001318605) (Issuer)
4 - GeoVax Labs, Inc. (0000832489) (Issuer)
AMC Burbank 16 in the Los Angeles market, AMC Town Square 18 in Las Vegas, AMC Gulf Pointe 30 in Houston, and AMC Barrywoods 24 in Kansas City have debuted new immersive premium formats as part of the companies' rollout to select AMC locations.BURBANK, Calif., March 19, 2026 /CNW/ -- CJ 4DPLEX, the world's leading producer of premium cinema formats and immersive theater technologies, and AMC Theatres (NYSE:AMC), the largest theatrical exhibitor in the United States and the world, today announced the opening of the first four premium format auditoriums developed under their strategic partnership. Two SCREENX at AMC auditoriums and two 4DX at AMC auditoriums have been completed across key loca
New stewards aim to restore company's status as America's innovation storeNEW YORK, March 19, 2026 /PRNewswire/ -- Stores.com announced today it has acquired Hammacher Schlemmer, aiming to reclaim the 178-year-old brand's mantle as the place for curious shoppers to discover "The Best, The Only, and The Unexpected". "Every Christmas season, there was one catalog I couldn't wait to get my hands on: Hammacher Schlemmer," says Matt Rutledge, CEO of Stores.com and founder and ex-CEO of Woot.com. "Now it just blows my mind that I've got the keys to the brand. And I can finally score o
The companies will collaborate on industry-leading HBM4 supply for AMD Instinct™ MI455X GPUs and next-generation DDR5 solutions for AMD EPYC™ processors and the AMD Helios platform Samsung Electronics Co., Ltd. today announced it has signed a Memorandum of Understanding (MOU) with AMD to expand their strategic collaboration on next-generation AI memory and computing technologies. The signing ceremony was held at Samsung's most advanced chip manufacturing complex in Pyeongtaek, Korea, attended by Dr. Lisa Su, Chair and CEO of AMD, and Young Hyun Jun, Vice Chairman & CEO of Samsung Electronics. "Samsung and AMD share a commitment to advancing AI computing, and this agreement reflects th
8-A12B - AMAZON COM INC (0001018724) (Filer)
8-K - Vistagen Therapeutics, Inc. (0001411685) (Filer)
8-K - AMC ENTERTAINMENT HOLDINGS, INC. (0001411579) (Filer)
Chicago, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Circana LLC, a leading global provider of data, insights, and advisory services, today announced the appointment of three new members to its Board of Directors: Brian Cornell, Executive Chair of Target Corp.; Lauren Cooks Levitan, Co-Founder and Co-CEO of ROOT and Lead Independent Director at e.l.f. Beauty, Inc.; and Rohit Prasad, former Senior Vice President and Head Scientist of Artificial General Intelligence at Amazon.com, Inc. "These appointments strengthen the Board's ability to guide Circana's strategy and accelerate the value we deliver to our global clients," said Stuart Aitken, President and CEO of Circana. "We are focused on advancing
SANTA CLARA, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Today AMD (NASDAQ:AMD) announced that Ariel Kelman has been appointed Senior Vice President and Chief Marketing Officer, effective immediately. Kelman will lead the AMD global marketing organization, overseeing brand, communications, events, developer relations and go-to-market strategy. Kelman will report to Ruth Cotter, Senior Vice President and Chief Administrative Officer, and will work closely with the AMD executive team to deepen engagement with customers, partners, developers and the broader technology ecosystem as AMD continues to scale its product and solutions leadership. "Ariel is a proven marketing leader with deep experi
SANTA CLARA, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- AMD (NASDAQ:AMD) today announced the appointment of KC McClure to its board of directors. McClure most recently served as a senior advisor to Accenture and was previously Chief Financial Officer of Accenture from 2019 to 2024. Throughout her more than 37-year tenure at Accenture, McClure held multiple finance and accounting leadership roles, including overseeing financial operations and investor relations. "We are delighted to welcome KC to AMD's Board of Directors," said Dr. Lisa Su, AMD chair and CEO. "KC is a proven finance leader whose operating expertise and global perspective will be an asset as we execute our strategy and exte
Generated TPOXX Product Revenues of $88 Million in 2025 Received $13 Million International Procurement Order for Oral TPOXX in January 2026 Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and twelve months ended December 31, 2025. "In 2025, we continued to advance SIGA's key long-term priorities, including securing $27 million in additional U.S. Government funding to support development activities, while generating $88 million in product revenues and $24 million in pre-tax operating income," stated Diem
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, March 10, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at http://www.siga.com in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-17
Fourth quarter operating income increases year-over-year and fourth quarter adjusted OIBDA exceeds guidance Fourth quarter revenue growth of 8% outpaced attendance as NCM attracted greater advertiser demand National CineMedia, Inc. (NASDAQ:NCMI) (the "Company" or "NCM"), the managing member of National CineMedia, LLC (NCM LLC), the operator of the largest cinema advertising platform in the U.S., announced today its consolidated results for the fiscal fourth quarter and year ended January 1, 2026. "NCM expanded fourth quarter revenue by 8% year-over-year, demonstrating the returns from our continued investment in our platform over the course of the year," said Tom Lesinski, Chief Execu
SC 13G/A - GeoVax Labs, Inc. (0000832489) (Subject)
SC 13G/A - Vistagen Therapeutics, Inc. (0001411685) (Subject)
SC 13G/A - Vistagen Therapeutics, Inc. (0001411685) (Subject)